| Product Code: ETC6744816 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Hereditary Angioedema Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Hereditary Angioedema Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Hereditary Angioedema Treatment Market - Industry Life Cycle |
3.4 China Hereditary Angioedema Treatment Market - Porter's Five Forces |
3.5 China Hereditary Angioedema Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 China Hereditary Angioedema Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Hereditary Angioedema Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) among healthcare professionals and patients in China |
4.2.2 Rising prevalence of HAE cases in China |
4.2.3 Advancements in treatment options and technologies for HAE in the Chinese market |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for HAE treatment in certain regions of China |
4.3.2 High costs associated with HAE treatment options in China |
4.3.3 Lack of standardized diagnostic procedures and treatment guidelines for HAE in China |
5 China Hereditary Angioedema Treatment Market Trends |
6 China Hereditary Angioedema Treatment Market, By Types |
6.1 China Hereditary Angioedema Treatment Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 China Hereditary Angioedema Treatment Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 China Hereditary Angioedema Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.4 China Hereditary Angioedema Treatment Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.1.5 China Hereditary Angioedema Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2 China Hereditary Angioedema Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Hereditary Angioedema Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 China Hereditary Angioedema Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 China Hereditary Angioedema Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China Hereditary Angioedema Treatment Market Import-Export Trade Statistics |
7.1 China Hereditary Angioedema Treatment Market Export to Major Countries |
7.2 China Hereditary Angioedema Treatment Market Imports from Major Countries |
8 China Hereditary Angioedema Treatment Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in HAE diagnosis and treatment in China |
8.2 Percentage increase in HAE diagnosis rates in China annually |
8.3 Adoption rate of new HAE treatment options in the Chinese market |
8.4 Patient adherence to prescribed HAE treatment regimens |
8.5 Number of clinical trials and research studies focusing on HAE treatment in China |
9 China Hereditary Angioedema Treatment Market - Opportunity Assessment |
9.1 China Hereditary Angioedema Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 China Hereditary Angioedema Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Hereditary Angioedema Treatment Market - Competitive Landscape |
10.1 China Hereditary Angioedema Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Hereditary Angioedema Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here